Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Topics
- (-) Neutron Science (2)
- (-) Security (1)
- 3-D Printing/Advanced Manufacturing (1)
- Artificial Intelligence (1)
- Biology (1)
- Biomedical (2)
- Chemical Sciences (2)
- Climate Change (2)
- Computer Science (5)
- Coronavirus (4)
- Cybersecurity (1)
- Energy Storage (1)
- Environment (1)
- High-Performance Computing (1)
- Isotopes (1)
- Machine Learning (1)
- Materials (2)
- Materials Science (2)
- Molten Salt (1)
- Nanotechnology (3)
- National Security (2)
- Physics (1)
- Summit (2)
- Sustainable Energy (1)
- Transportation (1)
Media Contacts
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
Horizon31, LLC has exclusively licensed a novel communication system that allows users to reliably operate unmanned vehicles such as drones from anywhere in the world using only an internet connection.